These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex. Tagami T, Barichello JM, Kikuchi H, Ishida T, Kiwada H. Int J Pharm; 2007 Mar 21; 333(1-2):62-9. PubMed ID: 17097247 [Abstract] [Full Text] [Related]
3. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S, Miller AD, Keller M. Biochemistry; 2004 Oct 26; 43(42):13348-56. PubMed ID: 15491141 [Abstract] [Full Text] [Related]
4. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. Wu RH, Cheng TL, Lo SR, Hsu HC, Hung CF, Teng CF, Wu MP, Tsai WH, Chang WT. J Gene Med; 2007 Jul 26; 9(7):620-34. PubMed ID: 17486668 [Abstract] [Full Text] [Related]
5. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases. Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y. J Control Release; 2005 Jul 20; 105(3):332-43. PubMed ID: 15936841 [Abstract] [Full Text] [Related]
13. In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription. Guissouma H, Froidevaux MS, Hassani Z, Demeneix BA. Neurosci Lett; 2006 Oct 09; 406(3):240-3. PubMed ID: 16930836 [Abstract] [Full Text] [Related]
14. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Fisch G, Dames S, Löffler K, Fechtner M, Arnold W, Giese K, Klippel A, Kaufmann J. Gene Ther; 2006 Aug 09; 13(16):1222-34. PubMed ID: 16625243 [Abstract] [Full Text] [Related]
15. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S, Benter I. Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774 [Abstract] [Full Text] [Related]
17. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D. Clin Cancer Res; 2005 Jun 15; 11(12):4487-94. PubMed ID: 15958634 [Abstract] [Full Text] [Related]